Xencor, Inc.
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS
Last updated:
Abstract:
The present invention is directed to bispecific, heterodimeric immunomodulatory antibodies.
Status:
Application
Type:
Utility
Filling date:
16 Mar 2020
Issue date:
1 Apr 2021